Gouty Arthritis

11 registered clinical trials studyying Gouty Arthritis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout NCT06887452	VA Office of Research and Development	N/A
Recruiting	Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients NCT07116746	Arthrosi Therapeutics	Phase 2
Completed	A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis NCT06068478	Tasly Pharmaceutical Group Co., Ltd	Phase 3
Recruiting	Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare NCT05658575	Olatec Therapeutics LLC	Phase 2 / Phase 3
Completed	The Impact of Metformin on the Outcome of Gouty Arthritis in a Cohort of Egyptian Gouty Patients. NCT05332795	Menoufia University	N/A
Unknown	Oral Huzhang Granules for Acute Gouty Arthritis NCT04462666	Shanghai Yueyang Integrated Medicine Hospital	Phase 2
Completed	Real-life Study of the Characteristics of Patients Treated With Ilaris® (Canakinumab) for Gouty Arthritis in F NCT05964946	Novartis Pharmaceuticals	—
Unknown	Role of ASICs in Human Inflammatory Pain NCT01867840	Centre Hospitalier Universitaire de Nice	—
Completed	AMPED Outcomes Registry of Post-ED Pain Management NCT01626235	Radnor Registry Research, Inc	—
Terminated	Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflamma NCT01362608	Novartis Pharmaceuticals	Phase 3
Completed	Long Term Study of Canakinumab (ACZ885) in Patients With Gout NCT00927810	Novartis Pharmaceuticals	Phase 2